3M, Minnesota Mining & manufacturing Company, ranks 45th in the Fortune 5oo & is a transnational corporation employing over 80,000 people worldwide. 3m Canada specializes in over 120 technologies marketed by 32 divisions. As Vice-President, John provided leadership to 11 divisions focused on laser imaging & data storage technology. He also served as corporate liaison with the federal & provincial governments.

In addition to his corporate responsibility, John served on the Board of Directors of ITAC (Information Technology Association of Canada). He chaired a task force on the innovative concept of "Solution Procurement" which provided a cost-effective process for the Canadian Government to acquire Information Management Systems. He was also a member of the Board of Directors of the Canadian Chamber of Commerce (1992-8), where in addition to the Executive committee he served on 4 standing committees.

Since 1983, John has been actively involved with St. Joseph's Health Care, London. He was Chair of the Board from 1989-91, leading the processes of Strategic Planning & Total Quality Management thus preparing the Heath Center for the "challenges" that lay ahead. As a founding member of the Teaching Hospitals Council, he promoted "Resource Sharing" which was a fundamental shift in health care delivery strategies. As Vice-Chair of the St.Joseph's Foundation he chaired a committee to develop a Strategic Plan for the next 5 years (2001-6). Effective July 2001 he was appointed Chair of the Board for the term 2001-3.

During his term as Chair of the Board of King's college, an affiliate of the University of Western Ontario, John facilitated the development of a Strategic Plan in the resource-scarce environment faced by academic institutions. John has served on the Board of the Monsignor Feeney Foundation since 1996 & was Chair 1999-2000.

In June of 1996, after 37 years at 3M, John elected to take an early retirement. Finding the need for a challenge, in August of 1997 John was appointed CEO of Sonometrics Corporation, a London based Medical Device Company. Sales grew each year from 97, & the company has been profitable enabling it to re-invest in product development thus enhancing its product line. In July 2001 John resigned from Sonometrics to pursue other interests.

Since the fall of 1999 John has been providing business planning assistance to a London based Bio-Tech, Critical Outcome Technologies, which uses a platform technology based on Artificial Intelligence to "Mine Molecules". John is currently CEO of COTI.